PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+13.06%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$16.6M
AUM Growth
+$16.6M
(+21%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-7,238.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
4
Reduced
2
Closed
1
Top Buys
| 1 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
$2.4M |
| 2 |
Outset Medical
OM
|
$1.34M |
| 3 |
Establishment Labs
ESTA
|
$960K |
| 4 |
Natera
NTRA
|
$418K |
| 5 |
Metagenomi
MGX
|
$283K |
Top Sells
| 1 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
$1.07B |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$142M |
| 3 |
KMTS
Kestra Medical Technologies, Ltd. Common Stock
KMTS
|
$997K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics, Inc. Common Stock
BBNX
$819M
| $6.25M | 37.57% | 2,500 -426,620 | -99% | -$1.07B |
|
|
IMDX
2
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $2.86M | 17.2% | 18,700 -928,434 | -98% | -$142M |
|
|
CAI
3
Caris Life Sciences, Inc. Common Stock
CAI
$10.8B
| $2.4M | 14.45% | +45,000 | New | +$2.4M |
|
|
4
Establishment Labs
ESTA
$1.2B
| $1.92M | 11.56% | 89,940 +44,940 | +100% | +$960K |
|
|
5
Outset Medical
OM
$247M
| $1.36M | 8.18% | 429,120 +424,120 | +8,482% | +$1.34M |
|
6
InspireMD
NSPR
$102M
| $1.02M | 6.15% | 450,517 | – | – |
|
|
7
Natera
NTRA
$23.1B
| $422K | 2.54% | 245,691 +243,191 | +9,728% | +$418K |
|
|
8
Metagenomi
MGX
$65.3M
| $391K | 2.35% | 952,134 +687,743 | +260% | +$283K |
|
|
KMTS
9
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$829M
| – | – | -40,000 | Closed | -$997K |
|